Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Unfractionated Heparin in Sepsis Caused by Abdominal Infection
NCT04861922Phase 3Unknown
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- May 2021
- Primary completion
- Dec 2023
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dextrose monohydrate + heparin sodium in sepsis, sponsored by Third Xiangya Hospital, Central South University. Status: unknown.
02
Drugs
dextrose monohydrate + heparin sodium
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT04861922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04861922.